Eli Lilly's 170% UK price hike for Mounjaro is just the start as pharma firms bow to Trump's pricing pressures
Pharma giants are navigating President Trump's demands to bring U.S. drug prices in line with other developed nations.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.